In a mouse model of depression, corticosterone-induced reduction in the number of hippocampal astrocytes was found to be caused by SGK1, and electroconvulsive therapy inhibited SGK1 expression and promoted the occurrence of antidepressant behavior (Miyako et al., 2024). Here, SGK1 is linked to depressive symptom measurement.